Sigma Planning’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Sigma Planning's MRNA Position: Q3 2026 in Review
Sigma Planning opened a new position in Moderna (MRNA) in Q3 2026: 1,492 shares worth $287K. The stake represents 0.01% of the portfolio and ranks #1083 among its holdings. This is a return to the name: Sigma Planning previously reported a position in MRNA as recently as Q1 2026.
Sigma Planning first reported a position in MRNA in Q1 2020 and has held it in 21 quarters since. The position peaked at $10.5M in Q3 2021. 858 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Sigma Planning held 1,492 shares of Moderna worth $287K as of Q3 2026.
- Moderna was a new Sigma Planning position in Q3 2026.
- Moderna made up 0.01% of Sigma Planning's portfolio in Q3 2026, its #1083 holding.
- Sigma Planning first reported a position in Moderna in Q1 2020 and has held it in 21 quarters since.
- Sigma Planning's Moderna position peaked at $10.5M in Q3 2021.
- 858 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Sigma Planning's 13F filing for Q3 2026, filed 23 Oct 2026.